C. Zheng and J. Hayes, Structures and interactions of the core histone tail domains, Biopolymers, vol.68, issue.4, pp.539-585, 2003.
DOI : 10.1002/bip.10303

K. Luger, M. Dechassa, and D. Tremethick, New insights into nucleosome and chromatin structure: an ordered state or a disordered affair?, Nature Reviews Molecular Cell Biology, vol.21, issue.7, pp.436-483, 2012.
DOI : 10.1016/j.gde.2011.01.022

D. Rossetto, N. Avvakumov, and J. Côté, Histone phosphorylation, Epigenetics, vol.109, issue.10, pp.1098-108, 2012.
DOI : 10.1038/nsmb.2310

A. Sawicka and C. Seiser, Histone H3 phosphorylation ??? A versatile chromatin modification for different occasions, Biochimie, vol.94, issue.11, pp.2193-201, 2012.
DOI : 10.1016/j.biochi.2012.04.018

S. Baek, When Signaling Kinases Meet Histones and Histone Modifiers in the Nucleus, Molecular Cell, vol.42, issue.3, pp.274-84, 2011.
DOI : 10.1016/j.molcel.2011.03.022

J. Dai, S. Sultan, S. Taylor, and J. Higgins, The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation and normal metaphase chromosome alignment, Genes & Development, vol.19, issue.4, pp.472-88, 2005.
DOI : 10.1101/gad.1267105

J. Eswaran, D. Patnaik, P. Filippakopoulos, F. Wang, R. Stein et al., Structure and functional characterization of the atypical human kinase haspin, Proceedings of the National Academy of Sciences, vol.53, issue.Pt 3, pp.20198-203, 2009.
DOI : 10.1107/S0907444996012255

T. Kang, D. Park, Y. Choi, K. Kim, H. Yoon et al., Mitotic Histone H3 Phosphorylation by Vaccinia-Related Kinase 1 in Mammalian Cells, Molecular and Cellular Biology, vol.27, issue.24, pp.8533-8579, 2007.
DOI : 10.1128/MCB.00018-07

E. Metzger, A. Imhof, D. Patel, P. Kahl, K. Hoffmeyer et al., Phosphorylation of histone H3T6 by PKC??I controls demethylation at histone H3K4, Nature, vol.8, issue.7289, pp.792-798, 2010.
DOI : 10.1038/nature08839

K. Lee and K. Song, Basal c-Jun N-terminal kinases promote mitotic progression through histone H3 phosphorylation. cell cycle, pp.216-237, 2008.

H. Goto, Y. Yasui, E. Nigg, and M. Inagaki, Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation, Genes to Cells, vol.15, issue.1, pp.11-18, 2002.
DOI : 10.1016/S0092-8674(00)80718-7

E. Metzger, N. Yin, M. Wissmann, N. Kunowska, K. Fischer et al., Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation, Nature Cell Biology, vol.85, issue.1, pp.53-60, 2008.
DOI : 10.1038/ncb1668

W. Yang, Y. Xia, D. Hawke, X. Li, J. Liang et al., PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis, Cell, vol.150, issue.4, pp.685-96, 2012.
DOI : 10.1016/j.cell.2012.07.018

U. Preuss, G. Landsberg, and K. Scheidtmann, Novel mitosis-specific phosphorylation of histone H3 at Thr11 mediated by Dlk/ZIP kinase, Nucleic Acids Research, vol.31, issue.3, pp.878-85, 2003.
DOI : 10.1093/nar/gkg176

M. Shimada, H. Niida, D. Zineldeen, H. Tagami, M. Tanaka et al., Chk1 Is a Histone H3 Threonine 11 Kinase that Regulates DNA Damage-Induced Transcriptional Repression, Cell, vol.132, issue.2, pp.221-253, 2008.
DOI : 10.1016/j.cell.2007.12.013

S. Hake, B. Garcia, M. Kauer, S. Baker, J. Shabanowitz et al., Serine 31 phosphorylation of histone variant H3.3 is specific to regions bordering centromeres in metaphase chromosomes, Proceedings of the National Academy of Sciences, vol.22, issue.3, pp.6344-6353, 2005.
DOI : 10.1128/MCB.22.3.874-885.2002

M. Dawson, A. Bannister, B. Göttgens, S. Foster, T. Bartke et al., JAK2 phosphorylates histone H3Y41 and excludes HP1?? from chromatin, Nature, vol.412, issue.7265, pp.819-841, 2009.
DOI : 10.1038/nature08448

P. Hurd, A. Bannister, K. Halls, M. Dawson, M. Vermeulen et al., Phosphorylation of Histone H3 Thr-45 Is Linked to Apoptosis, Journal of Biological Chemistry, vol.94, issue.24, pp.16575-83, 2009.
DOI : 10.1016/j.molcel.2005.08.032

V. Van-beusechem, J. Grill, D. Mastenbroek, T. Wickham, P. Roelvink et al., Efficient and Selective Gene Transfer into Primary Human Brain Tumors by Using Single-Chain Antibody-Targeted Adenoviral Vectors with Native Tropism Abolished, Journal of Virology, vol.76, issue.6, pp.2753-62, 2002.
DOI : 10.1128/JVI.76.6.2753-2762.2002

M. Hegi, A. Diserens, T. Gorlia, M. Hamou, N. De-tribolet et al., MGMT gene silencing and benefit from temozolomide in glioblastoma, N Engl J Med, vol.352, pp.991-1003, 2005.

M. Esteller, J. Garcia-foncillas, E. Andion, S. Goodman, O. Hidalgo et al., and the Clinical Response of Gliomas to Alkylating Agents, New England Journal of Medicine, vol.343, issue.19, pp.1350-1354, 2000.
DOI : 10.1056/NEJM200011093431901

S. Ma and R. S. Enzastaurin, Enzastaurin, Current Opinion in Oncology, vol.19, issue.6, pp.590-593, 2007.
DOI : 10.1097/CCO.0b013e3282f10a00

R. Wilkinson, R. Odedra, S. Heaton, S. Wedge, N. Keen et al., AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis, Clinical Cancer Research, vol.13, issue.12, pp.3682-3690, 2007.
DOI : 10.1158/1078-0432.CCR-06-2979

S. Ioannidis, M. Lamb, T. Wang, L. Almeida, M. Block et al., -pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway, Journal of Medicinal Chemistry, vol.54, issue.1, pp.262-76, 2011.
DOI : 10.1021/jm1011319

E. Galanis and J. Buckner, Enzastaurin in the Treatment of Recurrent Glioblastoma: A Promise That Did Not Materialize, Journal of Clinical Oncology, vol.28, issue.7, pp.1097-1105, 2010.
DOI : 10.1200/JCO.2009.26.1149

R. Rampling, M. Sanson, T. Gorlia, D. Lacombe, C. Lai et al., A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054), Neuro-Oncology, vol.28, issue.7, pp.344-50, 2012.
DOI : 10.1200/JCO.2009.26.1149

N. Butowski, S. Chang, K. Lamborn, M. Polley, R. Pieper et al., Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma, Neuro-Oncology, vol.27, issue.4, pp.1331-1339, 2011.
DOI : 10.1200/JCO.2008.18.9639
URL : https://academic.oup.com/neuro-oncology/article-pdf/13/12/1331/3775777/nor130.pdf

R. Diaz, B. Golbourn, M. Shekarforoush, C. Smith, and J. Rutka, Aurora kinase B/C inhibition impairs malignant glioma growth in vivo, Journal of Neuro-Oncology, vol.52, issue.3, pp.349-60, 2012.
DOI : 10.1016/j.jhep.2009.10.013

B. Mcfarland, J. Ma, C. Langford, G. Gillespie, H. Yu et al., Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma, Molecular Cancer Therapeutics, vol.10, issue.12, pp.2384-93, 2011.
DOI : 10.1158/1535-7163.MCT-11-0480

F. Wang and J. Higgins, Histone modifications and mitosis: countermarks, landmarks, and bookmarks, Trends in Cell Biology, vol.23, issue.4, pp.175-84, 2013.
DOI : 10.1016/j.tcb.2012.11.005

C. Crosio, G. Fimia, R. Loury, M. Kimura, Y. Okano et al., Mitotic Phosphorylation of Histone H3: Spatio-Temporal Regulation by Mammalian Aurora Kinases, Molecular and Cellular Biology, vol.22, issue.3, pp.874-85, 2002.
DOI : 10.1128/MCB.22.3.874-885.2002
URL : http://mcb.asm.org/content/22/3/874.full.pdf